Giunchi F.; Franceschini T.; Gruppioni E.; Altimari A.; Capizzi E.; Massari F.; Schiavina R.; Brunelli M.; Martignoni G.; Fiorentino M., Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis, «DIAGNOSTICS», 2020, 10, Article number: 123, pp. 123 - 123 [articolo]Open Access
Di Nunno V.; Santoni M.; Mollica V.; Conti A.; Montironi R.; Battelli N.; Ardizzoni A.; Massari F., Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients, «CLINICAL DRUG INVESTIGATION», 2020, 40, pp. 211 - 226 [articolo]
Mollica V.; Rizzo A.; Massari F., The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer, «FUTURE ONCOLOGY», 2020, 16, pp. 2029 - 2033 [articolo]
Cimadamore A.; Aurilio G.; Nole F.; Massari F.; Scarpelli M.; Santoni M.; Lopez-Beltran A.; Cheng L.; Montironi R., Update on circulating tumor cells in genitourinary tumors with focus on prostate cancer, «CELLS», 2020, 9, Article number: 1495, pp. 1 - 18 [articolo]Open Access
Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F, A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss., «MOLECULAR DIAGNOSIS & THERAPY», 2019, 23, pp. 569 - 577 [articolo]
Massari F.; Di Nunno V.; Mollica V.; Graham J.; Gatto L.; Heng D., Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta-Analysis of Available Clinical Trials, «CLINICAL GENITOURINARY CANCER», 2019, 17, pp. 339 - 344 [articolo]
Di Nunno, V.; Mollica, V.; Gatto, L.; Santoni, M.; Sorgentoni, G.; Battelli, N.; Massari, F., Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?, «ANNALS OF TRANSLATIONAL MEDICINE», 2019, 7, pp. 38 - 42 [articolo]
Di Nunno, Vincenzo; Massari, Francesco; Mollica, Veronica; Cimadamore, Alessia; Santoni, Matteo; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Montironi, Rodolfo, Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma, «ANNALS OF TRANSLATIONAL MEDICINE», 2019, 7, Article number: S137, pp. 1 - 6 [articolo]Open Access
Di Nunno V.; Frega G.; Santoni M.; Gatto L.; Fiorentino M.; Montironi R.; Battelli N.; Brandi G.; Massari F., BAP1 in solid tumors, «FUTURE ONCOLOGY», 2019, 15, pp. 2151 - 2162 [articolo]
Iacovelli, Roberto; Ciccarese, Chiara; Fornarini, Giuseppe; Massari, Francesco; Bimbatti, Davide; Mosillo, Claudia; Rebuzzi, Sara Elena; Di Nunno, Vincenzo; Grassi, Massimiliano; Fantinel, Emanuela; Ardizzoni, Andrea; Tortora, Giampaolo, Cabozantinib-related cardiotoxicity: a prospective analysis in a "real world" cohort of metastatic renal cell carcinoma patients, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2019, 85, pp. 1283 - 1289 [articolo]
Massari F.; Di Nunno V., CheckMate 214 patient-reported outcomes: listening to our patients, «THE LANCET ONCOLOGY», 2019, 20, pp. 179 - 180 [articolo]
Santoni M.; Cimadamore A.; Cheng L.; Lopez-Beltran A.; Battelli N.; Massari F.; Scarpelli M.; Galosi A.B.; Bracarda S.; Montironi R., Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges, «FRONTIERS IN ONCOLOGY», 2019, 9, Article number: 228, pp. 1 - 6 [articolo]Open Access
Gasparrini S.; Cimadamore A.; Scarpelli M.; Massari F.; Doria A.; Mazzucchelli R.; Cheng L.; Lopez-Beltran A.; Montironi R., Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians, «ASIAN JOURNAL OF ANDROLOGY», 2019, 21, pp. 19 - 23 [articolo]Open Access
Cimadamore A.; Gasparrini S.; Massari F.; Santoni M.; Cheng L.; Lopez-Beltran A.; Scarpelli M.; Montironi R., Emerging molecular technologies in renal cell carcinoma: Liquid biopsy, «CANCERS», 2019, 11, Article number: 196, pp. 1 - 9 [articolo]Open Access
Prisciandaro M.; Ratta R.; Massari F., Erratum: Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program (American Journal of Clinical Oncology: Cancer Clinical Trials (2019) 42 (42-45) DOI: 10.1097/COC.0000000000000478), «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2019, 42, pp. 412 - 412 [articolo]
